Inge Bernstein

Inge Bernstein serves as Chief Medical Consultant at Aalborg University Hospital within the Faculty of Health Sciences. She maintains active roles in hospital administration and clinical leadership while contributing significantly to research in hereditary colorectal cancer.

• Affiliation: Aalborg University Hospital, Faculty of Health Sciences
• Position: Chief Medical Consultant
• Leadership: Forum for Leading Senior Physicians AaUH (2015-2019), Danish Surgical Society Board of Directors (2013-2019)

Dr. Bernstein's research focuses on hereditary cancer syndromes, particularly Lynch syndrome and colorectal cancer genetics. Her work spans clinical management of hereditary cancer, colonoscopy quality metrics, cancer surveillance protocols, and translational research connecting DNA mismatch repair mechanisms to clinical outcomes. She has pioneered methods for diagnosing hereditary colon cancer and investigating stool-based cancer detection.

Analysis of her recent publications reveals a strong emphasis on practical clinical applications of genetic research, with particular attention to optimizing colonoscopy protocols for Lynch syndrome patients, understanding cancer risk stratification, and improving long-term outcomes for hereditary cancer patients. Her work bridges molecular genetics with clinical practice through large international collaborations like the Prospective Lynch Syndrome Database.

• Professional Committee - Danish Comprehensive Cancer Center (2020-present)
• Working group Colonoscopy education - DKS & DSGH (2019-present)
• HU Recruitment Committee Surgery REGION NORTH & SOUTH (2014-present)

Dr. Bernstein has been featured in multiple media outlets discussing her research on hereditary colon cancer diagnosis and stool-based cancer detection methods, demonstrating her commitment to translating complex medical research for public understanding.